262 related articles for article (PubMed ID: 34678218)
1. Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals.
Overbeek KA; Goggins MG; Dbouk M; Levink IJM; Koopmann BDM; Chuidian M; Konings ICAW; Paiella S; Earl J; Fockens P; Gress TM; Ausems MGEM; Poley JW; Thosani NC; Half E; Lachter J; Stoffel EM; Kwon RS; Stoita A; Kastrinos F; Lucas AL; Syngal S; Brand RE; Chak A; Carrato A; Vleggaar FP; Bartsch DK; van Hooft JE; Cahen DL; Canto MI; Bruno MJ;
Gastroenterology; 2022 Mar; 162(3):772-785.e4. PubMed ID: 34678218
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of neoplastic pancreatic cysts without high-risk stigmata: how often do we change treatment strategy because of malignant transformation?
Lekkerkerker SJ; Besselink MG; Busch OR; Dijk F; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
Scand J Gastroenterol; 2016 Sep; 51(9):1138-43. PubMed ID: 27175891
[TBL] [Abstract][Full Text] [Related]
3. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
4. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cysts: can surveillance interval for small low-risk lesions be lengthened?
Chong J; Wee NK; Tan CH; Low HM; Chew WD; Vu CKF; Lee CH
Acta Radiol; 2024 May; 65(5):406-413. PubMed ID: 38196245
[TBL] [Abstract][Full Text] [Related]
7. Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer.
Ohno E; Hirooka Y; Kawashima H; Ishikawa T; Kanamori A; Ishikawa H; Sasaki Y; Nonogaki K; Hara K; Hashimoto S; Matsubara H; Hirai T; Sumi H; Sugimoto H; Goto H;
J Gastroenterol Hepatol; 2018 Jan; 33(1):320-328. PubMed ID: 28872701
[TBL] [Abstract][Full Text] [Related]
8. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
[No Abstract] [Full Text] [Related]
9. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of asymptomatic pancreatic cysts in clinical practice: A vignette questionnaire.
Hol L; Bruno MJ; Cahen DL
Pancreatology; 2016; 16(3):416-22. PubMed ID: 26973156
[TBL] [Abstract][Full Text] [Related]
11. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
12. Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution.
Lawrence SA; Attiyeh MA; Seier K; Gönen M; Schattner M; Haviland DL; Balachandran VP; Kingham TP; D'Angelica MI; DeMatteo RP; Brennan MF; Jarnagin WR; Allen PJ
Ann Surg; 2017 Sep; 266(3):536-544. PubMed ID: 28657939
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
[TBL] [Abstract][Full Text] [Related]
14. Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas.
Pak LM; D'Angelica MI; DeMatteo RP; Kingham TP; Balachandran VP; Jarnagin WR; Allen PJ
J Gastrointest Surg; 2017 Oct; 21(10):1599-1605. PubMed ID: 28516310
[TBL] [Abstract][Full Text] [Related]
15. Timing and Clinical Features of Spontaneous Decrease in Size of Small Pancreatic Cystic Lesions without High-Risk Stigmata.
Lee HW; Lee SK; Jun JH; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Gut Liver; 2020 Mar; 14(2):248-256. PubMed ID: 31060116
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic Ultrasound-Based Pancreatic Cancer Screening of High-Risk Individuals: A Prospective Observational Trial.
Gangi A; Malafa M; Klapman J
Pancreas; 2018; 47(5):586-591. PubMed ID: 29683970
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.
Liu K; Joshi V; van Camp L; Yang QW; Baars JE; Strasser SI; McCaughan GW; Majumdar A; Saxena P; Kaffes AJ
World J Gastroenterol; 2017 Dec; 23(48):8526-8532. PubMed ID: 29358860
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions.
Yoshioka T; Shigekawa M; Ikezawa K; Tamura T; Sato K; Urabe M; Sueyoshi H; Yamai T; Suda T; Sakamori R; Tatsumi T; Takehara T
Pancreas; 2020 Apr; 49(4):552-560. PubMed ID: 32282769
[TBL] [Abstract][Full Text] [Related]
19. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
[TBL] [Abstract][Full Text] [Related]
20. Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?
Bartsch DK; Dietzel K; Bargello M; Matthaei E; Kloeppel G; Esposito I; Heverhagen JT; Gress TM; Slater EP; Langer P
Fam Cancer; 2013 Mar; 12(1):89-96. PubMed ID: 23179793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
